Rewiring of the 3D genome during acquisition of carboplatin resistance in a  triple-negative breast cancer patient-derived xenograft

Rewiring of the 3D genome during acquisition of carboplatin resistance in a triple-negative breast cancer patient-derived xenograft

4.8
(213)
Write Review
More
$ 24.00
Add to Cart
In stock
Description

Frontiers Wnt/β-Catenin Inhibition Disrupts Carboplatin

Three-Dimensional Tumor Models to Study Cancer Stemness-Mediated

3D chromatin organization of mammalian Hox loci. (a) Genomic

A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients. - Abstract - Europe PMC

Metabolic adaptation towards glycolysis supports resistance to

Identification of synergistic drug combinations using breast cancer patient-derived xenografts

Using RNA-seq and targeted nucleases to identify mechanisms of drug resistance in acute myeloid leukemia

Portfolio Details - dir VCU School of Medicine

Anti-MCUB antibody produced in rabbit Prestige Antibodies Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution CCDC109B

An avian embryo patient-derived xenograft model for preclinical

Microarray analysis revealed that H19 is an ALDH1-related gene. a

PDF) Rewiring of the 3D genome during acquisition of carboplatin resistance in a triple-negative breast cancer patient-derived xenograft